Safinamide
id:
safinamide-180-6490254
title:
Safinamide
text:
Safinamide, sold under the brand name Xadago, is a medication used as treatment for Parkinson's disease with "off" episodes; it has multiple modes of action, including the inhibition of monoamine oxidase B. It was approved in the European Union in February 2015, in the United States in March 2017, and in Canada in January 2019.
brand slug:
wiki
category slug:
encyclopedia
description:
Reversible monoamine oxidase B inhibitor
original url:
https://en.wikipedia.org/wiki/Safinamide
date created:
2008-08-18T05:31:00Z
date modified:
2024-09-05T09:07:56Z
main entity:
{"identifier":"Q2211523","url":"https://www.wikidata.org/entity/Q2211523"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/4c/Safinamide.svg","width":512,"height":200}
fields total:
13
integrity:
16